SCHEMBL30647680

SCHEMBL30647680

COC1CC(F)(c2cc(C(N)=O)c3ccccc3n2)C1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NCOA1 Q15788 1/20 0.43
▸ NCOA3 Q9Y6Q9 1/20 0.43
▸ PLA2G10 O15496 1/20 0.39
▸ KDM4E B2RXH2 4/20 0.39
▸ ALOX15 P16050 1/20 0.38
▸ ALDH1A1 P00352 4/20 0.37
▸ MAPT P10636 3/20 0.37
▸ POLB P06746 2/20 0.37
▸ GRM2 Q14416 1/20 0.37
▸ HTR3E A5X5Y0 1/20 0.37
▸ HTR3B O95264 1/20 0.37
▸ HTR3A P46098 1/20 0.37
▸ HTR3D Q70Z44 1/20 0.37
▸ HTR3C Q8WXA8 1/20 0.37
▸ NPC1 O15118 2/20 0.37
▸ RAB9A P51151 2/20 0.37
▸ PKM P14618 2/20 0.37
▸ LMNA P02545 1/20 0.37
▸ HPGD P15428 1/20 0.37
▸ NFKB1 P19838 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31266682 0.74 POLB (0.64) KDM4EALDH1A1MAPTPOLBNPC1
SCHEMBL30647640 0.74 POLB (0.64) KDM4EALDH1A1MAPTPOLBNPC1
SCHEMBL2372875 0.71 NCOA1 (0.50) NCOA1NCOA3PLA2G10KDM4EALDH1A1
SCHEMBL19691115 0.70 PLA2G10 (0.61) NCOA1NCOA3PLA2G10KDM4EALOX15
SCHEMBL7719697 0.68 L3MBTL1 (0.63) NCOA1NCOA3KDM4EALDH1A1NPC1
SCHEMBL31214767 0.68 NCOA1 (0.59) NCOA1NCOA3KDM4EPOLBGRM2
Hydrochloric Acid SCHEMBL28252270 0.67 L3MBTL1 (0.61) NCOA1NCOA3KDM4EALDH1A1NPC1
SCHEMBL28691005 0.66 NCOA1 (0.60) NCOA1NCOA3KDM4EPOLBGRM2
SCHEMBL9574610 0.66 NCOA1 (0.60) NCOA1NCOA3GRM2
SCHEMBL5202032 0.66 NCOA1 (0.65) NCOA1NCOA3KDM4EALDH1A1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4543878-A1 N-(2-(4-CYANOTHIAZOLIDIN-3-YL)-2-OXOETHYL)- QUINOLINE-4-CARBOXAMIDES Astrazeneca AB (SE) 2025-04-30 — — EP disclosed
WO-2023247489-A1 N-(2-(4-CYANOTHIAZOLIDIN-3-YL)-2-OXOETHYL)- QUINOLINE-4-CARBOXAMIDES ASTRAZENECA AB (SE) 2023-12-28 — — WO disclosed
Send feedback